Abstract 12623: Leadless Pacemaker Insertion is Safe in Pulmonary Hypertension Patients

• DOI: 10.1161/circ.148.suppl_1.12623
• Publication Date: 2023-12-19T07:50:21Z
• Authors: Ahmad Harb; Amjad Harb; Abdelraouf Salah; Bilal Al Kalaji; Yuliana Petryshyn; Amulya Reddy Dwaram; Mariam Khabsa; Naim Battikh; Amer Muhyieddeen; Aman Dutta; Richard Orji; Jashan Gill
• Keywords: Pericardiocentesis; Hemopericardium; Perforation

Introduction: Compared to conventional single-chamber pacemakers, leadless pacemakers (LPM) had a higher risk of pericardial effusion and/or perforation, but decreased other delayed device related complications. Pulmonary hypertension patients often have pressures in the adjacent right ventricle, possibly increasing perforation and Methods: The National Readmission Database years 2017 2020 were queried for who underwent LPM placement with ICD10 code (02HK3NZ). Patient comorbidities identified using appropriate codes. Multivariate logistic regression was used compare outcomes without pulmonary hypertension, adjusting patient shown Table 1. Results: We 26,084 placement, 4114 (15.77%) whom hypertension. There no statistically significant difference primary 30-day readmission (aOR 1.01, p 0.37, 95% CI 0.936 - 1.193), or mortality 0.973, 0.82, 0.769 1.232). composite outcome complications 0.729, 0.17, 0.462 1.149) which included hemopericardium, tamponade, need pericardiocentesis. However, postprocedure bleed 1.182, 0.036), hemothorax 2.493, 0.003), cardiogenic shock 2.447, p<0.001). Rest 2. Conclusions: Leadless pacemaker insertion appears be safe patients, although seem at increased bleeding